BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells.

Journal Article (Journal Article)

During chronic infection and cancer, a self-renewing CD8+ T cell subset maintains long-term immunity and is critical to the effectiveness of immunotherapy. These stem-like CD8+ T cells diverge from other CD8+ subsets early after chronic viral infection. However, pathways guarding stem-like CD8+ T cells against terminal exhaustion remain unclear. Here, we show that the gene encoding transcriptional repressor BACH2 is transcriptionally and epigenetically active in stem-like CD8+ T cells but not terminally exhausted cells early after infection. BACH2 overexpression enforced stem-like cell fate, whereas BACH2 deficiency impaired stem-like CD8+ T cell differentiation. Single-cell transcriptomic and epigenomic approaches revealed that BACH2 established the transcriptional and epigenetic programs of stem-like CD8+ T cells. In addition, BACH2 suppressed the molecular program driving terminal exhaustion through transcriptional repression and epigenetic silencing. Thus, our study reveals a new pathway that enforces commitment to stem-like CD8+ lineage and prevents an alternative terminally exhausted cell fate.

Full Text

Duke Authors

Cited Authors

  • Yao, C; Lou, G; Sun, H-W; Zhu, Z; Sun, Y; Chen, Z; Chauss, D; Moseman, EA; Cheng, J; D'Antonio, MA; Shi, W; Shi, J; Kometani, K; Kurosaki, T; Wherry, EJ; Afzali, B; Gattinoni, L; Zhu, Y; McGavern, DB; O'Shea, JJ; Schwartzberg, PL; Wu, T

Published Date

  • March 2021

Published In

Volume / Issue

  • 22 / 3

Start / End Page

  • 370 - 380

PubMed ID

  • 33574619

Pubmed Central ID

  • PMC7906956

Electronic International Standard Serial Number (EISSN)

  • 1529-2916

Digital Object Identifier (DOI)

  • 10.1038/s41590-021-00868-7


  • eng

Conference Location

  • United States